Examination of the effects of increasing G(s) protein on β2-adrenergic receptor, G(s), and adenylyl cyclase interactions

Biochemical Pharmacology

Volumn 54, Issue 1, 1997, Pages 61-72

  Krumins, Andrejs M ^a,b   Barber, Roger ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

2 adrenergic receptor; Adenylyl cyclase; G protein; GTP shift; Stoichiometry; Two state model

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; DEXAMETHASONE; DOBUTAMINE; FENOTEROL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; DEXAMETHASONE; DOBUTAMINE; ENZYME ACTIVATION; EPINEPHRINE; FENOTEROL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GUANOSINE TRIPHOSPHATE; MICE; MODELS, BIOLOGICAL; RATS; RECEPTORS, ADRENERGIC, BETA; TRANSFECTION;

EID: 0030843863     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00147-0     Document Type: Article

References (36)

1. s has greater functional activity than the 52-kDa α-subunit. J Biol Chem 264: 21106-21111, 1989.
2. s protein: Thyrotropin and forskolin increase the quantity of stimulatory guanine nucleotide-binding proteins in cultured thyroid follicles. J Biol Chem 265: 19942-19946, 1990.
3. Negishi M, Hashimoto H and Ichikawa A, Translocation of α subunits of stimulatory guanine nucleotide-binding proteins through stimulation of the prostacyclin receptor in mouse mastocytoma cells. J Biol Chem 267: 2364-2369, 1992.
4. sα activation of adenylyl cyclase. Biochem Pharmacol 54: 43-59, 1997.
5. DeLean A, Stadel JM and Lefkowitz RJ, A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase coupled β-adrenergic receptor. J Biol Chem 255: 7108-7117, 1980.
6. 2-adrenergic receptor: Extending the ternary complex model. J Biol Chem 268: 4625-4636, 1993.
7. Tolkovsky AM and Levitzki A, A mode of coupling between the β-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry 17: 3795-3810, 1978.
8. s-adenylate cyclase interactions. FASEB J 5: 2300-2303, 1991.
9. s and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692-694, 1989.
10. Milligan G, Gierschik P and Spiegel AM, The use of specific antibodies to identify and quantify guanine nucleotide-binding proteins. Biochem Soc Trans 15: 42-45, 1987.
11. Johnson GL, Kaslow HR and Bourne HR, Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase. J Biol Chem 253: 7120-7123, 1978.
12. Abramson SN, McGonigle P and Molinoff PB, Evaluation of models for analysis of radioligand binding data. Mol Pharmacol 31: 103-111, 1987.
13. Tolkovsky AM, Braun S and Levitzki A, Kinetics of interaction between β-receptors, GTP protein, and the catalytic unit of turkey erythrocyte adenylate cyclase. Proc Natl Acad Sci USA 79: 213-217, 1982.
14. s and the catalytic unit of adenylate cyclase are tightly associated: Mechanistic consequences. Proc Natl Acad Sci USA 81: 6579-6583, 1984.
15. Citri Y and Schramm M, Resolution, reconstitution and kinetics of the primary action of a hormone receptor. Nature 287: 297-300, 1980.
16. Gilman AG, G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 56: 615-649, 1987.
17. - murine lymphoma cells. J Neurochem 58: 1093-1103, 1992.
18. - cells. Mol Pharmacol 39: 702-710, 1991.
19. Van den Hoff MJB, Moorman AFM and Lamers WH, Electroporation in "intracellular" buffer increases cell survival. Nucleic Acids Res 20: 2902, 1992.
20. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
21. 125I]Iodocyanopindolol, a highly selective radioiodinated β-adrenergic receptor antagonist: Measurement of β-adrenergic receptors on intact astrocytoma cells. J Cyclic Nucleotide Res 6: 297-307, 1980.
22. Hoyer D, Reynolds EE and Molinoff PB, Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Mol Pharmacol 25: 209-218, 1984.
23. Salomon Y, Londos D and Rodbell M, A highly sensitive adenylate cyclase assay. Anal Biochem 58: 541-548, 1974.
24. Clark RB, Kunkel MW, Friedman J, Goka TJ and Johnson JA, Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. Proc Natl Acad Sci USA 85: 1442-1446, 1988.
25. q/11, its physiologic regulator. Cell 70: 411-418, 1992.
26. May DC, Ross EM, Gilman AG and Smigel MD, Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J Biol Chem 260: 15829-15833, 1985.
27. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
28. Birnbaumer L, Abramowitz J and Brown AM, Receptor-effector coupling by G-proteins. Biochim Biophys Acta 1031: 163-224, 1990.
29. Whaley BS, Yuan N, Birnbaumer L, Clark RB and Barber R, Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: A quantitative evaluation. Mol Pharmacol 45: 481-489, 1994.
30. Richardson MD. Ph.D. Thesis. University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, 1994.
31. 2-adrenergic receptors in purified membranes from human platelets: Implications of receptor-inhibitory nucleotide binding protein stoichiometry. Mol Pharmacol 28: 475-486, 1985.
32. i2, of neural cloned cells and their changes during differentiation. J Neurochem 53: 1195-1198, 1989.
33. s. J Biol Chem 263: 9482-9485, 1988.
34. Neubig RR, Membrane organization in G-protein mechanisms. FASEB J 8: 939-946, 1994.
35. s-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J Biol Chem 268: 3833-3837, 1993.
36. Barber R, Forskolin binding to intact S49 lymphoma cells. Second Messengers Phosphoproteins 12: 59-71, 1988.